A. Clayton Perfall
Known title: DirectorCIK: 0001262173
Associated companies
Transaction History
| ENOV | ▲ Buy | Grant | 9,346 | $0 | 5/19/2026 | View on chart |
| ENOV | ▲ Buy | Grant | 6,598 | $0 | 5/21/2025 | View on chart |
| ENOV | ▲ Buy | Grant | 4,338 | $0 | 5/20/2024 | View on chart |
| ENOV | ▲ Buy | Grant | 1,875 | $0 | 5/16/2023 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 2,793 | $119K | 3/16/2023 | View on chart |
| ENOV | ▼ Sell | Open Market | 2,793 | $146K | 3/16/2023 | View on chart |
| ENOV | ▲ Buy | Grant | 444 | $0 | 12/30/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 516 | $0 | 9/30/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 432 | $0 | 6/30/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 1,648 | $0 | 6/7/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 411 | $0 | 4/18/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 599 | $0 | 12/31/2021 | View on chart |
| ENOV | ▲ Buy | Grant | 600 | $0 | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Enovis joins AAOS Registry Program as industry sponsor
Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.
Enovis joins AAOS Registry Program as industry sponsor. Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.